Russell Swerdlow on Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease.
COMMENT This study advances the AD biomarker field by identifying a new marker, in this case cerebrospinal fluid (CSF) mitochondrial DNA (mtDNA) levels. The authors present data that suggest CSF mtDNA changes precede CSF Aβ changes. While one must use caution whe